Table 1.
Patient’s Laboratory Results Throughout His Clinical Course.
| Variable | Reference range | Value during hospitalization | Value at 3 months of treatment |
|---|---|---|---|
| White blood cell count | 4.5-11 × 103/µL | 5.1 × 103/µL | 6 × 103/µL |
| Hemoglobin | 13.5-17.5 g/dL | 10.6 g/dL | 11.5 g/dL |
| Hematocrit | 40% to 51% | 31.6% | 33% |
| Mean corpuscular volume | 80-100 fL | 81.4 fL | 85.7 fL |
| C-reactive protein | <0.9 mg/dL | 13.2 mg/dL | <0.05 mg/dL |
| Erythrocyte sedimentation rate | 0-15 mm/h | 73 mm/h | 47 mm/h |
| Lactate dehydrogenase | <201 U/L | 708 U/L | 246 U/L |
| Ferritin | 20-300 ng/mL | 10 842 ng/mL | 512.2 ng/mL |
| Activated partial thromboplastin time | 24-37 seconds | 43.6 seconds | 37.5 seconds |
| Serum IL-2 | ≤2.0 pg/mL | 1538.4 pg/mL | — |
| Serum IL-6 | 175.3-858.2 pg/mL | 7.1 pg/mL | — |
| C2 | 1.6-4 mg/dL | 4.9 mg/dL | 2.7 mg/dL |
| C3 | 83-180 mg/dL | 190 mg/dL | 164 mg/dL |
| C4 | 18-55 mg/dL | 67 mg/dL | 51 mg/dL |
| C5 | 7-20 mg/dL | 23 mg/dL | 28 mg/dL |
| Total complement activity | 38.7-89.9 U/mL | >95 U/mL | 80.8 U/mL |
| AST | <45 U/L | 351 U/L | 24 U/L |
| ALT | <46 U/L | 320 U/L | 17 U/L |
| ALP | 20-120 U/L | 137 U/L | 60 U/L |
| GGT | <81 U/L | 131 U/L | 17 U/L |
| Triglycerides | <150 mg/dL | 209 mg/dL | 195 mg/dL |
| Uric acid | 3.5-7.5 mg/dL | 3.5 mg/dL | 7.9 mg/dL |
Abbreviations: IL, interleukin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; GGT, γ-glutamyltransferase.